Ankylosing spondylitis and Idiopathic retroperitoneal fibrosis

Summary:

Idiopathic retroperitoneal fibrosis is found among people with Ankylosing spondylitis, especially for people who are male, 50-59 old.

The study analyzes which people have Idiopathic retroperitoneal fibrosis with Ankylosing spondylitis. It is created by eHealthMe based on reports of 23 people who have Ankylosing spondylitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

23 people who have Ankylosing Spondylitis and Idiopathic Retroperitoneal Fibrosis are studied.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 1,396 drugs and 869 conditions by eHealthMe.

What is Idiopathic retroperitoneal fibrosis?

Idiopathic retroperitoneal fibrosis (disorder that blocks the tubes (ureters) that carry urine) is found to be associated with 509 drugs and 368 conditions by eHealthMe.

Number of Idiopathic retroperitoneal fibrosis in Ankylosing spondylitis reports submitted per year:

Would you have Idiopathic retroperitoneal fibrosis when you have Ankylosing spondylitis?

Gender of people who have Ankylosing Spondylitis and experienced Idiopathic Retroperitoneal Fibrosis *:

female: 18.18 %
male: 81.82 %

Age of people who have Ankylosing Spondylitis and experienced Idiopathic Retroperitoneal Fibrosis *:

Common co-existing conditions for these people *:

Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Pleural Effusion (water on the lungs): 4 people, 17.39%
Back Pain: 3 people, 13.04%
Weight Increased: 2 people, 8.70%
Large Intestinal Ulcer: 2 people, 8.70%
Blood Creatinine Increased: 2 people, 8.70%
Colitis (inflammation of colon): 2 people, 8.70%
Colonic Stenosis (abnormal narrowing of colon): 2 people, 8.70%
Diarrhea: 2 people, 8.70%
Diarrhea Haemorrhagic: 2 people, 8.70%
Fever: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Idiopathic retroperitoneal fibrosis?

Check whether Idiopathic retroperitoneal fibrosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .

Related studies

Treatments, associated drugs and conditions:

Ankylosing spondylitis (105,477 reports)
Idiopathic retroperitoneal fibrosis (948 reports)

COVID vaccines that are related to Idiopathic retroperitoneal fibrosis:

All the drugs that are associated with Idiopathic retroperitoneal fibrosis:

Idiopathic retroperitoneal fibrosis (509 drugs)

All the conditions that are associated with Idiopathic retroperitoneal fibrosis:

Idiopathic retroperitoneal fibrosis (368 conditions)

How the study uses the data?

The study is based on Idiopathic retroperitoneal fibrosis and Ankylosing spondylitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.